Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 9—September 2023
Research

Molecular Characterization of Circulating Yellow Fever Viruses from Outbreak in Ghana, 2021–2022

Joseph Humphrey Kofi BonneyComments to Author , Terrel Sanders, Deborah Pratt, Bright Agbodzi, Dennis Laryea, Nana Kwame Fredua Agyeman, Selassie Kumordjie, Keren Attiku, Patience Lartekai Adams, Gideon Aning Boateng, Sally-Ann Ohene, Christopher Tamal, Gifty Mawuli, Clara Yeboah, Samuel Dadzie, Chrysantus Kubio, Franklin Asiedu-Bekoe, and John Kofi OdoomComments to Author 
Author affiliations: Noguchi Memorial Institute for Medical Research Virology Department, Legon Accra, Ghana (J.H.K. Bonney, D. Pratt, K. Attiku, P.L. Adams, G.A. Boateng, G. Mawuli, J.K. Odoom); US Naval Medical Research Unit, No. 3, Ghana Detachment, Accra, Ghana (T. Sanders, B. Agbodzi, S. Kumordjie, C. Yeboah); Ghana Health Service Public Health Unit, Accra (D. Laryea, N.K.F. Agyeman, F. Asiedu-Bekoe); World Health Organization Ghana Country Office, Accra (S.-A. Ohene, C. Tamal); Noguchi Memorial Institute for Medical Research Department of Parasitology, Legon Accra (S. Dadzie); Ghana Health Service–Savannah Regional Health Directorate, Damongo, Ghana (C. Kubio)

Main Article

Table 3

Demographics and signs/symptoms of patients in study of yellow fever in Ghana, 2021–2022

Variable Yellow fever test results
 p value
Negative, n = 118 Positive, n = 70
Sex 0.078
M 58 (50.4) 44 (63.8)
F
 57 (49.6)
 25 (36.2)
Median age, y (interquartile range)
 7 (4–19)
 11 (4–23.5)
 0.172
Region
Central, Greater Accra, Western 14 (12.2) 1 (1.4) <0.001
Ashanti, Bono East 15 (13.0) 0
Savannah 65 (56.5) 58 (84.1)
Upper East, Upper West, Northern, North East 21 (18.3) 10 (14.5)
Unknown
 3
 1
Signs/symptoms
Fever 62/88 (70.5) 44/55 (70.0) 0.205
Jaundice 3/47 (6.4) 2/51 (3.9) 0.58
Hemorrhage 4/118 (3.4) 7/70 (10.0) 0.062
Other† 39/118 (33.1) 35/70 (50.0) 0.021

*Values are no. (%) except as indicated. †Muscle and joint pain, abdominal pain, difficulty swallowing, difficulty breathing, hiccups, loss of appetite, skin rash, anorexia, myalgia, dizziness, malaise, agitation, swollen buttocks, convulsions, chills, runny nose, chest pain, cough, and lethargy

Main Article

Page created: July 20, 2023
Page updated: September 07, 2023
Page reviewed: September 07, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external